Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Paolo Tambaro

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Blood|February 21, 2020
How I manage CLL with venetoclax-based treatmentsWilliam G Wierda, Francesco Paolo Tambaro
The Lancet. Haematology|February 1, 2020
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendationsFrancesco Paolo Tambaro, William G Wierda
Expert Opinion on Therapeutic Patents|May 29, 2009
Histone acetyltransferase inhibitors and preclinical studiesFabio Manzo, Francesco Paolo Tambaro, Antonello Mai, et al.
Journal of Experimental Pharmacology|November 8, 2021
The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical ViewFrancesco Paolo Tambaro, Danilo De Novellis, William G Wierda
Plos Genetics|June 8, 2018
Cancer epigenetics: Moving forwardAngela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, et al.
Clinical Epigenetics|July 3, 2026
Azacitidine and decitabine show distinct response patterns in pediatric Myelodysplastic Syndromes and Juvenile Myelomonocytic Leukemia before HSCT: a systematic review and quantitative analysisAlessandra Cianflone, Francesco Cecere, Luigi Coppola, et al.
Biosensors|March 29, 2023
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care PatientsFabrizio Clemente, Amina Antonacci, Maria Teresa Giardi, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Seminars in Cancer Biology|April 1, 2023
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectivesUgo Chianese, Chiara Papulino, Wout Megchelenbrink, et al.
Pharmaceutics|December 28, 2021
The TKI Era in Chronic LeukemiasDanilo De Novellis, Fabiana Cacace, Valeria Caprioli, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Blood|February 21, 2020
How I manage CLL with venetoclax-based treatmentsWilliam G Wierda, Francesco Paolo Tambaro
The Lancet. Haematology|February 1, 2020
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendationsFrancesco Paolo Tambaro, William G Wierda
Expert Opinion on Therapeutic Patents|May 29, 2009
Histone acetyltransferase inhibitors and preclinical studiesFabio Manzo, Francesco Paolo Tambaro, Antonello Mai, et al.
Journal of Experimental Pharmacology|November 8, 2021
The Role of BTK Inhibition in the Treatment of Chronic Lymphocytic Leukemia: A Clinical ViewFrancesco Paolo Tambaro, Danilo De Novellis, William G Wierda
Plos Genetics|June 8, 2018
Cancer epigenetics: Moving forwardAngela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, et al.
Clinical Epigenetics|July 3, 2026
Azacitidine and decitabine show distinct response patterns in pediatric Myelodysplastic Syndromes and Juvenile Myelomonocytic Leukemia before HSCT: a systematic review and quantitative analysisAlessandra Cianflone, Francesco Cecere, Luigi Coppola, et al.
Biosensors|March 29, 2023
Last Trends in Point-of-Care (POC) Diagnostics for the Management of Hematological Indices in Home Care PatientsFabrizio Clemente, Amina Antonacci, Maria Teresa Giardi, et al.
Clinical Epigenetics|June 19, 2012
Histone deacetylase inhibitors: clinical implications for hematological malignanciesFrancesco Paolo Tambaro, Carmela Dell'aversana, Vincenzo Carafa, et al.
Seminars in Cancer Biology|April 1, 2023
Epigenomic machinery regulating pediatric AML: Clonal expansion mechanisms, therapies, and future perspectivesUgo Chianese, Chiara Papulino, Wout Megchelenbrink, et al.
Pharmaceutics|December 28, 2021
The TKI Era in Chronic LeukemiasDanilo De Novellis, Fabiana Cacace, Valeria Caprioli, et al.
Pageof 5